Balguerie Pharmaceutical Import Profile — France (DGFT 2022–2026)

Name: Balguerie Pharmaceutical Import Records from India — 2 Products, $600.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Balguerie — Pharmaceutical Importer Profile (2026) | 2 Products, $600.0K Trade | TransData Nexus

Balguerie

Pharmaceutical Importer · France · Nutritional Supplements Focus · $600.0K Total Trade · DGFT Verified

Balguerie is a pharmaceutical importer based in France with a total trade value of $600.0K across 2 products in 2 therapeutic categories. Based on 12 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Balguerie sources from 2 verified Indian suppliers, with Caplin Point Laboratories Limited accounting for 97.6% of imports.

Balguerie — Import Portfolio & Supplier Network

Balguerie import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Balguerie?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Caplin Point Laboratories Limited	$4.3M	136	97.6%
Kwality Pharmaceuticals Limited	$106.1K	5	2.4%

Balguerie sources from 2 verified Indian suppliers across .

What Formulations Does Balguerie Import?

Formulation	Value	Ships
Cefixime capsules 400MG	$250.0K	5
Cefixime for oral suspension USP	$190.9K	4
Ferfoltone (ferrous fumarate + folic acid capsules)	$186.0K	4
Caprazole	$182.3K	4
Gencloben (gentamycin , betamethasone	$150.0K	3
Cefixime capsules 400MG ceficap cefixime gelules 400MG	$150.0K	3
Fezomin -c ( haematinics and vitamins capsules)	$143.9K	3
Calben oral suspension (albendazole oralsuspension USP 400MG/10ML)	$125.1K	5
Lanzocap (lansoprazole capsules 30MG)	$100.0K	2
Ciprofloxacin and tinidazole tablets	$100.0K	2
Ceficap capsules	$100.0K	2
Ferfoltone ( ferrous fumarate + folic acid capsules )	$81.3K	2
Calben oral suspension (albendazole	$80.1K	2
Erythromycin stearate tablets USP 500MG	$78.7K	2
Caplin-cary 250 erythromycin for oral suspension 250MG/5ML - 60ML	$75.2K	2

Balguerie imports 91 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Folic	Nutritional Supplements	$400.0K	8	0.7%	17
2	Tinidazole	Advanced Antibiotics	$200.0K	4	1.1%	6

Balguerie imports 2 pharmaceutical products across 2 categories into France totaling $600.0K.

Balguerie — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Balguerie is a family-owned logistics company founded in 1930, headquartered in Bordeaux, France. The company specializes in international freight forwarding, customs brokerage, specialized logistics, consolidation, warehousing, and distribution services. With a staff of approximately 1,250 employees and a turnover of €650 million, Balguerie operates across 51 locations, including subsidiaries in Barcelona and Antwerp, and a participation in the Léon Vincent Group.

While Balguerie is primarily known for its comprehensive logistics services, it also engages in the importation of pharmaceutical products. Between 2022 and 2026, the company imported finished pharmaceutical formulations from India, totaling $600,000 across 12 shipments. The imported products included folic acid and tinidazole, categorized under nutritional supplements and advanced antibiotics, respectively. This indicates Balguerie's involvement in the pharmaceutical supply chain, focusing on the importation and distribution of finished dosage forms.

2Distribution Network

Balguerie operates a robust distribution network with 51 locations, including major ports and airports in France, as well as international subsidiaries in Barcelona and Antwerp. The company's logistics capabilities encompass sea, air, and road freight, offering full container load (FCL), less than container load (LCL), and specialized equipment such as flat racks and temperature-controlled containers. Additionally, Balguerie provides multimodal transport solutions and has a dedicated customs clearance team to facilitate efficient import and export operations.

3Industry Role

In France's pharmaceutical supply chain, Balguerie functions as a logistics intermediary, facilitating the importation and distribution of pharmaceutical products. While the company is not a primary wholesaler or parallel importer, its role in managing the logistics of pharmaceutical imports is crucial. By leveraging its extensive network and expertise in customs brokerage, Balguerie ensures the efficient movement of pharmaceutical goods from suppliers to the French market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Balguerie

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Balguerie's pharmaceutical imports from India are highly concentrated, with 97.6% of shipments sourced from Caplin Point Laboratories Limited and 2.4% from Kwality Pharmaceuticals Limited. This single-source dependency may pose a risk in terms of supply chain stability, as any disruptions with these suppliers could impact Balguerie's ability to meet market demand. The limited number of suppliers also suggests a strategic choice to maintain quality control and streamline logistics operations. However, the lack of diversification in sourcing could be a vulnerability if alternative suppliers are not readily available.

2Supply Chain Resilience

Balguerie's supply chain resilience is closely tied to its reliance on a limited number of Indian suppliers. The absence of backup suppliers and the focus on a narrow range of formulations imported from India indicate potential vulnerabilities. Diversifying the supplier base and increasing the variety of formulations could enhance supply chain resilience. Additionally, assessing the stability and regulatory compliance of key suppliers is essential to mitigate risks associated with supply chain disruptions.

3Strategic Implications

Importing Pharmaceuticals into France — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for France

1Regulatory Authority & Framework

In France, the Agence nationale de sécurité du médicament et des produits de santé (ANSM) is the primary regulatory authority overseeing the safety and efficacy of medicinal products. The French Public Health Code (Code de la santé publique) governs the manufacture, import, and distribution of pharmaceutical products. Key legislation includes Articles R5121-108 to R5121-111, which outline the requirements for import authorization of medicinal products.

2Import Licensing & GMP

Import authorization is mandatory for each import operation of finished pharmaceutical products into France. Applicants must submit a request to the ANSM, providing details such as the name and address of the importer, country of origin, product information, and quantities imported. Additionally, imported products must comply with Good Manufacturing Practice (GMP) standards recognized by the European Union, WHO, or PIC/S. Importers must ensure that their suppliers hold valid GMP certificates to meet these regulatory requirements.

3Quality & Labeling

Balguerie — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Balguerie's focus on importing folic acid and tinidazole aligns with market demand in France for nutritional supplements and advanced antibiotics. The prevalence of conditions requiring these treatments, such as anemia and bacterial infections, drives the need for these products. By sourcing these specific therapeutic areas, Balguerie addresses critical healthcare needs while leveraging its logistics expertise to ensure timely and efficient distribution.

2Sourcing Profile

Balguerie's sourcing strategy emphasizes importing finished pharmaceutical formulations from India, particularly focusing on folic acid and tinidazole. This approach allows the company to offer ready-to-use products that meet French regulatory standards. India's established pharmaceutical manufacturing capabilities and cost-effectiveness make it a strategic partner for Balguerie in fulfilling the French market's requirements.

3Market Positioning

Balguerie's product mix positions it to serve various segments of the French pharmaceutical market, including retail pharmacies, hospitals, and government tenders. By importing essential medications like folic acid and tinidazole, the company contributes to the availability of critical treatments across different healthcare settings. Its logistics capabilities further enhance its ability to meet the diverse needs of the French pharmaceutical supply chain.

Seller's Guide — How to Become a Supplier to Balguerie

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Balguerie, especially if they can offer a diverse range of pharmaceutical formulations that complement Balguerie's existing portfolio. Identifying gaps in Balguerie's current sourcing, such as the need for additional therapeutic areas or formulations, could present avenues for collaboration. Ensuring compliance with French regulatory standards and demonstrating the ability to meet quality and supply chain requirements will be crucial for new suppliers seeking to establish a partnership.

2Requirements & Qualifications

Indian exporters aiming to supply Balguerie and the French market must obtain GMP certificates recognized by the European Union, WHO, or PIC/S. They must also ensure that their products comply with French labeling requirements, including French language labeling and serialization mandates. Additionally, adherence to French import authorization procedures, including providing detailed product information and quantities, is essential.

3How to Approach

Frequently Asked Questions — Balguerie

What products does Balguerie import from India?

Balguerie imports 2 pharmaceutical products across 2 categories. Top imports: Folic ($400.0K), Tinidazole ($200.0K).

Who supplies pharmaceuticals to Balguerie from India?

Balguerie sources from 2 verified Indian suppliers. The primary supplier is Caplin Point Laboratories Limited (97.6% of imports, $4.3M).

What is Balguerie's total pharmaceutical import value?

Balguerie's total pharmaceutical import value from India is $600.0K, based on 12 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Balguerie focus on?

Balguerie imports across 2 categories. The largest: Nutritional Supplements (66.7%), Advanced Antibiotics (33.3%).

Get Full Balguerie Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.